Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Declining Consumer Sales “Weak Spot” In J&J’s Otherwise Solid Q1

This article was originally published in The Tan Sheet

Executive Summary

Worldwide consumer sales for the period fell 3.2% to $3.6 billion, compared with the same period last year, while overall sales for the company climbed 3.5% to $18.1 billion, J&J announced April 14. Analysts say the weaker-than-expected results raise questions about the firm’s progress in turning around the consumer division following quality-control problems and ongoing remediation efforts under a 2011 consent decree.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel